The risk of developing type 2 diabetes (T2D) among youth who take selective serotonin reuptake inhibitors (SSRIs) may be lower than previously reported, new research suggests.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045
Type 2 Diabetes Risk in Youth Using SSRIs Appears Lower Than Previously Reported
Default sub title
minute read
by Psychiatric News | October 14, 2020
